COLORECTAL AND GASTRIC CANCER IN 2015: The development of new agents and molecular classifications

    loading  Checking for direct PDF access through Ovid


In a little over the past year, several clinical trials have evaluated new drugs in patients with metastatic colorectal cancer and gastric cancer. Furthermore, genomics studies that attempted to unravel the molecular characteristics of colorectal and gastric cancer were published in 2015. The results of these endeavours will influence clinical practice in 2016 and beyond.

Related Topics

    loading  Loading Related Articles